Biotia is a health tech company, launched from Jacobs Technion-Cornell Institute Cornell Tech in association with Weill Cornell Medicine, located in New York, NY that leverages DNA sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance.

Our founding team is composed of Dr. Niamh B. O'Hara (CEO), Dr. Christopher E. Mason (Global Director and Associate Professor at Weill Cornell Medicine), and Dr. Rachid Ounit (CTO), experts who have pioneered advances in the identification and mapping of microbes and antimicrobial resistance.